Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00081926 · COMPLETED
Trial details
- NCT number
- NCT00081926
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.